ID: ALA5219601

Max Phase: Preclinical

Molecular Formula: C26H43N9O8

Molecular Weight: 609.69

Associated Items:

Representations

Canonical SMILES:  CN1C(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@@H]1C1CCCCC1

Standard InChI:  InChI=1S/C26H43N9O8/c1-35-21(14-6-3-2-4-7-14)24(42)34-15(22(27)40)9-10-18(36)32-16(8-5-11-30-26(28)29)23(41)31-13-19(37)33-17(25(35)43)12-20(38)39/h14-17,21H,2-13H2,1H3,(H2,27,40)(H,31,41)(H,32,36)(H,33,37)(H,34,42)(H,38,39)(H4,28,29,30)/t15-,16-,17-,21-/m0/s1

Standard InChI Key:  DNLQADUOEVWNMM-IAGYGMIVSA-N

Associated Targets(Human)

Integrin alpha-V/beta-6 509 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-5/beta-1 686 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 609.69Molecular Weight (Monoisotopic): 609.3235AlogP: -3.02#Rotatable Bonds: 8
Polar Surface Area: 279.00Molecular Species: ZWITTERIONHBA: 8HBD: 9
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.05CX Basic pKa: 12.07CX LogP: -5.63CX LogD: -5.63
Aromatic Rings: 0Heavy Atoms: 43QED Weighted: 0.08Np Likeness Score: 0.66

References

1. Tomassi S, D'Amore VM, Di Leva FS, Vannini A, Quilici G, Weinmüller M, Reichart F, Amato J, Romano B, Izzo AA, Di Maro S, Novellino E, Musco G, Gianni T, Kessler H, Marinelli L..  (2021)  Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand.,  64  (10.0): [PMID:33961417] [10.1021/acs.jmedchem.1c00533]

Source